Characterizing ImmuneMediated Cytopenias After Allogeneic Hematopoietic Cell Transplantation
- Slides: 5
Characterizing Immune-Mediated Cytopenias After Allogeneic Hematopoietic Cell Transplantation for Pediatric Nonmalignant Disorders Robert T. Galvin, Qing Cao, Weston P. Miller, Jessica Knight-Perry, Angela R. Smith, Christen L. Ebens Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy Volume 27 Issue 4 Pages 316. e 1 -316. e 8 (April 2021) DOI: 10. 1016/j. jtct. 2021. 015 Copyright © 2021 The American Society for Transplantation and Cellular Therapy Terms and Conditions
Figure 1 Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy 2021 27316. e 1 -316. e 8 DOI: (10. 1016/j. jtct. 2021. 015) Copyright © 2021 The American Society for Transplantation and Cellular Therapy Terms and Conditions
Figure 2 Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy 2021 27316. e 1 -316. e 8 DOI: (10. 1016/j. jtct. 2021. 015) Copyright © 2021 The American Society for Transplantation and Cellular Therapy Terms and Conditions
Figure 3 Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy 2021 27316. e 1 -316. e 8 DOI: (10. 1016/j. jtct. 2021. 015) Copyright © 2021 The American Society for Transplantation and Cellular Therapy Terms and Conditions
Figure 4 Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy 2021 27316. e 1 -316. e 8 DOI: (10. 1016/j. jtct. 2021. 015) Copyright © 2021 The American Society for Transplantation and Cellular Therapy Terms and Conditions
